Effect of Intraoperative Lidocaine Use during Cardiac Surgeries on the Hemodynamic and the Intraoperative Opioid Drugs Use.

Hemodynamic and Analgesic Effects of Intravenous Infusion of Lidocaine in Patients Undergoing Cardiac Surgeries.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202204496465842

Enrollment

Registered

2022-04-22

Start date

2019-02-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Anaesthesia

Interventions

lidocaine

saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Age from 18 to 60y. -both sex. -ASA physical status II&III. -Patients scheduled for elective cardiac surgery (valve replacement or coronary artery bypass surgery).

Exclusion criteria

Exclusion criteria: -Patients refusal. -allergy to the study drug. -emergent cardiac surgery. -redo cardiac surgery. -combined coronary artery bypass surgery/ valve replacement surgery. -ejection fraction less than 40%. -liver disease.

Design outcomes

Primary

Measure	Time frame
systolic arterial blood pressure (SABP). ;diastolic arterial blood pressure ;mean arterial blood pressure;heart rate	—

Secondary

Measure	Time frame
amount of intraoperative fentanyl used.	—

Countries

Egypt

Contacts

Public ContactMay Badr

lecturer of anesthesia and ICU

mayelsherbiny7@gmail.com00201007193959

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026